Effect of Dapagliflozin Treatment on Index of Cardiac Electrophysiological Balance in Patients With Heart Failure With Reduced Ejection Fraction
Open Access
- 4 August 2025
- journal article
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 30 (5) , e70101
Abstract
Background: Dapagliflozin (DAPA), a sodium‐glucose cotransporter‐2 (SGLT2) inhibitor, may attenuate the risk of ventricular arrhythmia (VA) through its antiarrhythmic properties in patients with heart failure with reduced ejection fraction (HFrEF). The antiarrhythmic mechanisms of SGLT2 inhibitors are not fully known. Recently, the index of cardiac electrophysiological balance (ICEB) has been posited as a robust indicator for predicting VA risk. ICEB reflects the balance between ventricular depolarization and repolarization. This study was conducted to investigate the effects of DAPA treatment on ICEB in a cohort of patients with HFrEF.Methods: A total of 235 HFrEF patients undergoing DAPA treatment were enrolled in the study. Each participant underwent a comprehensive 12‐lead electrocardiography (ECG) assessment prior to treatment initiation and approximately 6 months posttreatment. ICEB values were compared before and after treatment.Results: The analysis revealed a statistically significant reduction in the QT interval (427.51 ± 13.87 vs. 347.75 ± 11.21 ms, p < 0.001), corrected QT interval (QTc) (458.34 ± 29.71 vs. 393.37 ± 13.21 ms, p < 0.001), T peak‐to‐end (Tp‐e) interval (85.41 ± 3.52 vs. 71.18 ± 3.16 ms, p < 0.001), Tp‐e/QTc ratio (0.186 ± 0.009 vs. 0.180 ± 0.003, p < 0.001), ICEB (4.59 ± 0.65 vs. 3.77 ± 0.15, p < 0.001), following approximately 6 months of DAPA treatment.Conclusion: In addition to ventricular repolarization distribution indices, the regression of the ICEB values after DAPA treatment in patients with HFrEF shows that DAPA treatment improves the balance between ventricular depolarization and repolarization and reduces the risk of VA in these patients.Keywords
This publication has 41 references indexed in Scilit:
- Evaluation of Tpe interval and Tpe/QT ratio in patients with slow coronary flowThe Anatolian Journal of Cardiology, 2015
- A new biomarker – index of Cardiac Electrophysiological Balance (iCEB) – plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs)Journal of Pharmacological and Toxicological Methods, 2013
- KDIGO Clinical Practice Guidelines for Acute Kidney InjuryNephron Clinical Practice, 2012
- Prolonged Tpeak-to-Tend Interval on the Resting ECG Is Associated With Increased Risk of Sudden Cardiac DeathCirculation: Arrhythmia and Electrophysiology, 2011
- Ventricular Tachycardia and Sudden Cardiac DeathMayo Clinic Proceedings, 2009
- Does Tpeak–Tend provide an index of transmural dispersion of repolarization?Heart Rhythm, 2007
- Tpeak-Tend and Tpeak-Tend Dispersion as Risk Factors for Ventricular Tachycardia/Ventricular Fibrillation in Patients With the Brugada SyndromeJACC, 2006
- Nonsustained ventricular tachycardia in severe heart failure.1997
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- Delayed Ventricular Repolarization as an Anti-Arrhythmic PrincipleEuropean Heart Journal, 1985